49 related articles for article (PubMed ID: 19861565)
1. Titrimetric immunohistochemical evaluation of DNA hypomethylation in uterine tumours.
Wolk M; Martin JE
J Clin Pathol; 2009 Nov; 62(11):1039-42. PubMed ID: 19861565
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kokawa K; Shikone T; Otani T; Nakano R
Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575
[TBL] [Abstract][Full Text] [Related]
3. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
6. DNA aneuploidy in invasive carcinoma of the uterine cervix.
Kashyap V; Bhambhani S
Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
[TBL] [Abstract][Full Text] [Related]
7. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples.
de Capoa A; Musolino A; Della Rosa S; Caiafa P; Mariani L; Del Nonno F; Vocaturo A; Donnorso RP; Niveleau A; Grappelli C
Oncol Rep; 2003; 10(3):545-9. PubMed ID: 12684621
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor (VDR) expression is not a prognostic factor in cervical cancer.
Friedrich M; Meyberg R; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
Anticancer Res; 2002; 22(1A):299-304. PubMed ID: 12017307
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
10. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix.
Lee TS; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
Ann N Y Acad Sci; 2006 Dec; 1091():218-24. PubMed ID: 17341616
[TBL] [Abstract][Full Text] [Related]
11. Prognostic DNA methylation marker in serum of cancer patients.
Müller HM; Fiegl H; Widschwendter A; Widschwendter M
Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
13. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
17. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.
Sikora J; Słodkowska J; Radomyski A; Giedronowicz D; Kobos J; Kupis W; Rudzinski P
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():271-9. PubMed ID: 9337544
[TBL] [Abstract][Full Text] [Related]
19. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
Lindström AK; Tot T; Stendahl U; Syrjänen S; Syrjänen K; Hellberg D
Anticancer Res; 2009 Jul; 29(7):2577-8. PubMed ID: 19596931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]